Sacituzumab 是一种人源化 IgG1 单克隆抗体，与抗滋养层细胞表面抗原 2 (anti-Trop-2) 结合。Sacituzumab 具有用于转移性三阴性乳腺癌研究的潜力。
| 生物活性 | Sacituzumab is a humanizedIgG1monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breastcancerresearch[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
